Back

TACE gene expression and soluble receptors TNFRI and TNFRII levels identifies very high risk cardiovascular patients

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Prevention general Biomarkers ESC Premium Access ESC Congress 2017

About the speaker

Photo
Miss Melody Chemaly

Massachusetts General Hospital - Harvard Medical School, Boston (United States of America)

27 More presentations in this session

Presentation thumbnail
Professor F. Saad (Berlin, DE)
Abstract Slides
Presentation thumbnail
Professor J. Argacha (Brussels, BE)
Abstract Slides
Presentation thumbnail
Doctor N. Arnold (Hamburg, DE)
Abstract
Presentation thumbnail
Doctor J. Wu (Toufen, TW)
Abstract Slides
Presentation thumbnail
Professor S. Boldueva (Saint Petersburg, RU)
Abstract

Access the full session

Session thumbnail
Poster session 7 - Prevention general

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Circulating LIGHT/TNFSF14 levels are negatively associated with cardiovascular mortality, while intra-plaque levels are associated with symptomatic cerebrovascular disease
13 April 2024
thumbnail
Congress Presentation
Effects of combining coronary calcium score with treatment on plaque progression in familial coronary artery disease: CAUGHT-CAD RCT
1 September 2025
thumbnail
Congress Presentation
Circulating ACE2 and the association of endothelial progenitor cell in CAD patients
1 September 2024
thumbnail
Congress Presentation
Mechanisms of vascular inflammaging: TNF-alpha mediates endothelial CEACAM1 expression by NF-KB and beta-Catenin in a biphasic manner
12 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources